Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant for recent onset chronic cough
2019-002308-42Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic cough comparing Gefapixant with Placebo (2 arms). Primary endpoint: Change from baseline in Leicester Cough Questionnaire total score. Started Oct 2019; status: completed.
02
Drugs
gefapixant
03
Conditions
chronic cough
Beyond the preview
Go deeper on 2019-002308-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002308-42.